ctDNA as a prognostic factor for colon cancer

Please introduce yourself, your research background and current research interests. My name is Emre Yekedüz. I am a clinical oncology fellow in Ankara University Medical Oncology Department (Turkey). This is the last year in my fellowship. My main research areas of interest are gastrointestinal and genitourinary cancers. How can ctDNA be used as a prognostic factor in colon cancer? There have been numerous studies regarding the use of circulating tumor DNA (ctDNA) in metastatic colorectal cancer patients. However, the use of ctDNA in early colon cancer patients is a new research area. Historically, patients nominated for adjuvant chemotherapy have been...